首页> 外国专利> Oligonucleotide and the use thereof for modulating an isoform C beta-1 protein-kinase in the form of a skin depigmentation agent

Oligonucleotide and the use thereof for modulating an isoform C beta-1 protein-kinase in the form of a skin depigmentation agent

机译:寡核苷酸及其在调节皮肤脱色剂形式的同工型C beta-1蛋白激酶中的用途

摘要

Oligonucleotide (ON), containing 7-25, preferably 20, nucleotides, that can hybridize specifically with the gene, or gene product, encoding protein kinase C beta -1 (PKCb1) is new. ACTIVITY : Dermatological. No details of tests for dermatological activity are given. MECHANISM OF ACTION : Inhibiting melanin synthesis by preventing expression of PKCb1, an enzyme involved in the first step (phosphorylation of tyrosine) of melanin biosynthesis. M4Beu melanocytes were cultured for 3 days in presence of 1 mu M oligonucleotide (1) ACAC 4AGGCTCAACGATG (1) then the confluent cells washed; lysed; proteins separated by electrophoresis, and the membrane incubated with labeled antibody against human PCKb1, followed by chemiluminescent detection. Inhibition of PKCb1 was 100% at the protein level and 55% at the level of RNA expression.
机译:含有7-25个核苷酸(最好是20个核苷酸)的寡核苷酸(ON)可以与编码蛋白激酶Cβ-1(PKCb1)的基因或基因产物特异性杂交。活动:皮肤科。没有给出皮肤活性的测试细节。作用机理:通过阻止PKCb1的表达来抑制黑色素的合成,PKCb1是黑色素生物合成的第一步(酪氨酸磷酸化)所涉及的一种酶。在1μM寡核苷酸的存在下,将M4Beu黑素细胞培养3天(1)ACAC 4AGGCTCAACGATG(1),然后洗涤融合细胞;溶解通过电泳分离蛋白质,然后将膜与针对人PCKb1的标记抗体一起温育,然后进行化学发光检测。 PKCb1的抑制在蛋白质水平上为100%,在RNA表达水平上为55%。

著录项

  • 公开/公告号KR101403128B1

    专利类型

  • 公开/公告日2014-06-19

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR20067015293

  • 发明设计人 커퍼스트 로빈;니자드 캐린;

    申请日2004-12-28

  • 分类号C12N15/54;C12N15/11;

  • 国家 KR

  • 入库时间 2022-08-21 15:40:48

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号